Skip to content
TrialScanner

NCT04307953

Saracatinib Trial TO Prevent FOP

Phase 2Active, not recruitingAZNCollaborator

Registry record

Lead sponsor
Amsterdam UMC, location VUmc
Conditions
Fibrodysplasia Ossificans Progressiva
Primary completion
Nov 30, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04307953 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04307953: Saracatinib Trial TO Prevent FOP | TrialScanner